FTC investigating Schering/Organon merger
Executive Summary
The Federal Trade Commission is requesting additional information from Schering-Plough regarding its planned acquisition of Akzo Nobel's pharmaceutical and animal health business, Organon Biosciences. Despite FTC's request, Schering continues to expect the $14.4 billion transaction to be completed by the end of 2007 (1"The Pink Sheet" March 26, 2007, p. 25)...
You may also be interested in...
Schering Sees Growth Opportunity For Organon Products In The U.S. – Hassan
Schering-Plough sees significant growth potential for Organon's products that currently are marketed in the U.S., CEO Fred Hassan said March 20
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.